GGrantIndex
← Leaderboards

Greg M. Delgoffe

University Of Pittsburgh At Pittsburgh

$10,560,525
Attributed
$11,907,428
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY201225
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,907,428 · 10

By mechanism

R01$7,417,854 · 3
DP2$2,301,101 · 1
P50$1,535,479 · 3
R21$429,601 · 1
F32$121,077 · 1
P30$102,316 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsCellsT-LymphocyteImmuneEnvironmentMetabolicImmunotherapyMetabolismCell PhysiologyTumorTumor MicroenvironmentImmunityFunctional DisorderResponseTissuesIn VivoDesignGenesIn VitroTumor ImmunityEpigenetic ProcessGenetic TranscriptionProgrammed Cell Death Protein 1Hypoxia

Grant awards (24)

Uncovering the metabolic underpinnings of T cell exhaustion$1,280,768
R01 · FY2025 · AI · contact PI
Dissecting the role of hypoxia in T cell differentiation in cancer$614,462
R01 · FY2025 · CA · contact PI
Metabolic control of regulatory T cell functional identity$602,526
R01 · FY2025 · AI · contact PI
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)$318,776
P50 · FY2025 · CA · contact PI
Project 5: Microenvironment manipulation using anti-angiogenics to improve immunotherapy in melanoma$276,920
P50 · FY2025 · CA · contact PI
Cancer Immunology and Immunotherapy Program$45,251
P30 · FY2025 · CA · contact PI
Uncovering the metabolic underpinnings of T cell exhaustion$640,384
R01 · FY2024 · AI · contact PI
Metabolic control of regulatory T cell functional identity$602,526
R01 · FY2024 · AI · contact PI
Dissecting the role of hypoxia in T cell differentiation in cancer$583,740
R01 · FY2024 · CA · contact PI
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)$305,980
P50 · FY2024 · CA · contact PI
Cancer Immunology and Immunotherapy Program$57,065
P30 · FY2024 · CA · contact PI
Uncovering the metabolic underpinnings of T cell exhaustion$640,384
R01 · FY2023 · AI · contact PI
Dissecting the role of hypoxia in T cell differentiation in cancer$614,462
R01 · FY2023 · CA · contact PI
Metabolic control of regulatory T cell functional identity$602,526
R01 · FY2023 · AI · contact PI
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)$316,751
P50 · FY2023 · CA · contact PI
Uncovering the metabolic underpinnings of T cell exhaustion$633,550
R01 · FY2022 · AI · contact PI
Metabolic control of regulatory T cell functional identity$602,526
R01 · FY2022 · AI · contact PI
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)$317,052
P50 · FY2022 · CA · contact PI
Illuminating metabolic pathways enabled by early T cell activation$198,785
R21 · FY2019 · AI · contact PI
Illuminating metabolic pathways enabled by early T cell activation$230,816
R21 · FY2018 · AI · contact PI
Exploring and exploiting metabolic plasticity in regulatory T cells$2,301,101
DP2 · FY2017 · AI · contact PI
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells$19,673
F32 · FY2014 · AI · contact PI
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells$52,190
F32 · FY2013 · AI · contact PI
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells$49,214
F32 · FY2012 · AI · contact PI